|

NGM120 Q4W Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • NGM Biopharmaceuticals, Inc1

Indications

  • Cancer Cachexia1
  • CRC (Colorectal Cancer)1
  • Colorectal Cancer1
  • Cancer1

Laredo, Texas1 trial

An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

NGM Clinical Study Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.